COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,959 Articles (22,604 medRxiv, 8,355 bioRxiv)

Most recent first Previous |  Page 298: Articles 2971-2980  | Next

Surrogate virus neutralisation test based on nanoluciferase-tagged antigens to quantify inhibitory antibodies against SARS-CoV-2 and characterise Omicron-specific reactivity
Schoefbaenker, M., Neddermeyer, R., Guenther, T., Mueller, M. M., Romberg, M. L., Classen, N., Hennies, M. T., Hrincius, E. R., Ludwig, S., Kuehn, J. E., Lorentzen, E. U.
10.1101/2023.10.10.23296792 — Posted: 2023-10-10
Scaling COVID-19 rates with population size in the United States
Cruz, A. R., Enquist, B. J., Burger, J. R.
10.1101/2023.10.10.23296807 — Posted: 2023-10-10
Perceptions of access to harm reduction services during the COVID-19 pandemic among people who inject drugs in Chicago
Kristensen, K., Boodram, B., Avila, W., Pineros, J., Latkin, C., Mackesy-Amiti, M.-E.
10.1101/2023.10.10.23296820 — Posted: 2023-10-10
SHIFTR enables the unbiased and multiplexed identification of proteins bound to specific RNA regions in live cells
Aydin, J., Gabel, A., Zielinski, S., Ganskih, S., Schmidt, N., Hartigan, C. R., Schenone, M., Carr, S. A., Munschauer, M.
10.1101/2023.10.09.561498 — Posted: 2023-10-10
SARS-CoV-2 antibodies cross-react and enhance dengue infection
Jakhar, K., Sonar, S., Singh, G., Sarkar, T., Tiwari, M., Kaur, J., Rathore, D. K., Lal, B., Kumar, S., Srivastav, P., Kumar, S., Phagna, V., Kumar, L., Gupta, V., Kshetrapal, P., Singh, S., Wadhwa, N., Thiruvengadam, R., Raghavan, S., Gosain, M., Shrivastava, T., Bhattacharyya, S., Bhattacharya, J., Asthana, S., Mani, S.
10.1101/2023.10.09.557914 — Posted: 2023-10-10
Deep learning-guided selection of antibody therapies with enhanced resistance to current and prospective SARS-CoV-2 Omicron variants
Frei, L., Gao, B., Han, J., Taft, J. M., Irvine, E. B., Weber, C. R., Kumar, R., Eisinger, B., Reddy, S. T.
10.1101/2023.10.09.561492 — Posted: 2023-10-10
Clinical impact and cost-effectiveness of the updated COVID-19 mRNA Autumn 2023 vaccines in Germany
Joshi, K., Scholz, S., Maschio, M., Kohli, M., Lee, A., Fust, K., Ultsch, B., van de Velde, N., Beck, E.
10.1101/2023.10.09.23296505 — Posted: 2023-10-10
Non-pharmacological interventions aimed at promoting the mental health of children and adolescents during the COVID-19 pandemic
Quiroga, C. V., Caobelli, A. C. S. L., Rodrigues, G. V. A., Viola, T. W.
10.1101/2023.10.07.23296694 — Posted: 2023-10-09
Immunomodulators and risk for breakthrough infection after third COVID-19 mRNA vaccine among patients with rheumatoid arthritis: A cohort study
Schiff, A. E., Wang, X., Patel, N. J., Kawano, Y., Kowalski, E. N., Cook, C. E., Vanni, K. M. M., Qian, G., Bade, K. J., Saavedra, A. A., Srivatsan, S., Williams, Z. K., Venkat, R. K., Wallace, Z. S., Sparks, J. A.
10.1101/2023.10.08.23296717 — Posted: 2023-10-09
Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size
Duncan, M. C., Omondi, F. H., Kinloch, N. N., Lapointe, H. R., Speckmaier, S., Moran Garcia, N., Lawson, T., DeMarco, M. L., Simons, J., Holmes, D. T., Lowe, C. F., Bacani, N., Sereda, P., Barrios, R., Harris, M., Romney, M. G., Montaner, J. S. G., Brumme, C. J., Brockman, M. A., Brumme, Z. L.
10.1101/2023.10.08.23296718 — Posted: 2023-10-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).